DelveInsight's "Becker Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Becker Muscular Dystrophy (BMD), historical and forecasted epidemiology as well as the Becker Muscular Dystrophy (BMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Becker Muscular Dystrophy (BMD) is an inherited muscle structure disorder that results in progressive deterioration of limbs, cardiac and skeletal muscles. However, the involuntary muscles are not affected. BMD is milder version of Duchenne Muscular Dystrophy (DMD). BMD usually begins in the teens or early adulthood, and the course is slower and far less predictable than that of DMD.
· According to the Genetic and Rare Diseases Information Center, the prevalence of BMD is estimated to be between 17–27 cases per million people. This means that at a given time,about one in 37,000 to one in 59,000 people are living with BMD.
· According to the Centers for Disease Control and Prevention (CDC), the estimated prevalence of Duchenne and Becker muscular dystrophy (DBMD) was one in every 7,250 males aged 5–24 years. However, the prevalence of DMD was found to be three times higher than the prevalence of BMD.
· Through several studies, it can be estimated that the occurrence of BMD varies from one per 18,000 to one per 31,000 male births.
· According to a study conducted by Walter et al. titled “Recent developments in Duchenne muscular dystrophy: facts and numbers”, the worldwide prevalence of BMD is estimated to be 1.53 per 100,000 males and according to recent calculations of the German population, about 600 BMD patients are supposed to live in Germany.
Request for Sample Pages: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
· The report covers the descriptive overview of Becker Muscular Dystrophy (BMD), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
· Comprehensive insight has been provided into the Becker Muscular Dystrophy (BMD) epidemiology and treatment in the 7MM
· Additionally, an all-inclusive account of both the current and emerging therapies for Becker Muscular Dystrophy (BMD) is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
· A detailed review of the Becker Muscular Dystrophy (BMD) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
· The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Becker Muscular Dystrophy (BMD) market
· PTC Therapeutics
· Italfarmaco
· Epirium Bio
· Edgewise Therapeutics
· And Many Others
Request for Sample Pages: https://www.delveinsight.com/report-store/becker-muscular-dystrophy-market
· Translarna
· Givinostat
· EPM-01
· EDG-5506
· And Many Others
Table of Content:
1. Key Insights
2. Executive Summary of Becker Muscular Dystrophy (BMD)
3. Competitive Intelligence Analysis for Becker Muscular Dystrophy (BMD)
4. Becker Muscular Dystrophy (BMD): Market Overview at a Glance
5. Becker Muscular Dystrophy (BMD): Disease Background and Overview
6. Patient Journey
7. Becker Muscular Dystrophy (BMD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Becker Muscular Dystrophy (BMD) Unmet Needs
10. Key Endpoints of Becker Muscular Dystrophy (BMD) Treatment
11. Becker Muscular Dystrophy (BMD) Marketed Products
12. Becker Muscular Dystrophy (BMD) Emerging Therapies
List to be continued in report
13. Becker Muscular Dystrophy (BMD): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Becker Muscular Dystrophy (BMD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer